Patients with or without metastatic disease, for whom the standard oncology treatment regime is not viable, tolerable, available or providing benefit, are able to enter the study at the clinic, which evaluates the clinical impact of using a combination of existing medicines, which provides an acceptable quality of life, while fighting the disease.
Cancer cells differ substantially from normal cells in the way they metabolise food to energy. These differences are well established and existing prescription medicines target these processes.
These medicines have been used by a large number of people over a long period of time, have known and acceptable side effects and have beneficial impacts on cancer.
The Care Oncology Clinic study will evaluate the effectiveness and tolerability of combinations of these established medicines on the growth rate of cancers (or metabolic impacts) to determine their potential in slowing down the growth and spread of cancer cells. The Clinic will be studying the effects of these medicines in various different cancers, while
treating patients at the same time.
These data will be collected and analysed using standard procedures and processes and shared in the future with the medical community .
Patients, who wish to attend the clinic and enrol in the study, will need to be referred to the Care Oncology Clinic by their health care professional. If you are interested in the study and require assistance with this process, contact us on +44 207 580 3266 or email us at firstname.lastname@example.org.
Please see a recently published article about the clinic APM article